Neoadjuvant Chemotherapy A New Therapeutic Challenge in Treatment of Ovarian Cancer- A Review

Authors

  • Rahul G. Ingle School of Pharmacy, S.R.T.M.University, Nanded, Maharashtra
  • Shailesh Wadher Asso Professor SRTM University
  • Rajiv Jadhav

DOI:

https://doi.org/10.7439/ijpc.v5i9.2415

Abstract

As per literature survey reveals that ovarian cancer is the most lethal gynecologic malignancy in females all over the world. In majority of patients who suffering from ovarian cancer clinical complete remissions are obtained through combinations of cytoreductive surgery and chemotherapy. This review represents an overview of the origin of ovarian cancer, history of chemotherapeutic regimens and also focused on chemotherapeutic agents which are useful in the treatment of ovarian cancer. Taxanes are most promising drug used in neoadjuvant chemotherapy. This review adds better advances in medical field may be based on the better understanding of drugs regimens and better control of cost in routine practice which opens the new doors for neoadjuvant chemotherapy which proves a better option in ovarian cancer treatment.

Downloads

Downloads

Published

2015-10-04

Issue

Section

Review Article

How to Cite

1.
Neoadjuvant Chemotherapy A New Therapeutic Challenge in Treatment of Ovarian Cancer- A Review. Int J of Pharm Chem [Internet]. 2015 Oct. 4 [cited 2025 Jun. 5];5(9):293-6. Available from: https://ssjournals.co.in/index.php/ijpc/article/view/2415